申请人:ADIR et Compagnie
公开号:US05854273A1
公开(公告)日:1998-12-29
A compound of formula (I) ##STR1## in which: X and Y, which may be identical or different, represent hydrogen or halogen or alkyl, trihaloalkyl, alkoxy, hydroxyl, cyano, nitro, amino, alkylamino, or dialkylamino, Z represent a linear or branched C.sub.4 to C.sub.12 alkylene chain in which one or more --CH.sub.2 -- are optionally replaced by any one of the following atoms or groups: --NR--, --O--, --S--, --SO--, --SO.sub.2 --, or --CONH--, A forms, with two adjacent carbon atoms of the phenyl ring, a phenyl, naphthyl or tetrahydronaphthyl ring or a heterocycle, ##STR2## represents any one of the groups as defined in the description, its optical isomers and its addition salts with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful as anticancer agents.
化合物的化学式为(I)##STR1## 其中:X和Y可以相同或不同,代表氢或卤素或烷基,三卤代烷基,烷氧基,羟基,氰基,硝基,氨基,烷基氨基或二烷基氨基,Z代表线性或支链烷基链,长度为C.sub.4到C.sub.12,其中一个或多个--CH.sub.2-- 可以被以下任何一个原子或基团替代:--NR--,--O--,--S--,--SO--,--SO.sub.2--或--CONH--,A与苯环的两个相邻碳原子形成苯基,萘基或四氢萘基环或杂环,##STR2## 表示如描述中定义的任何一个基团,其光学异构体及其与药用可接受酸或碱的加成盐,以及含有它们的药物产品,用作抗癌剂。